The heparins and cancer: review of clinical trials and biological properties.
about
Trousseau's syndrome: multiple definitions and multiple mechanismsEffect of non-anticoagulant N-desulfated heparin on expression of vascular endothelial growth factor, angiogenesis and metastasis of orthotopic implantation of human gastric carcinoma.Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel.Significance of neo-angiogenesis and immuno-surveillance cells in squamous cell carcinoma of the tongue.Heparin impairs angiogenesis through inhibition of microRNA-10b.Guidelines for treatment and prevention of venous thromboembolism among patients with cancer.HARE-Mediated Endocytosis of Hyaluronan and Heparin Is Targeted by Different Subsets of Three Endocytic Motifs.The influence of low molecular weight heparin on the expression of osteogenic growth factors in human fracture healingHeparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering.Activation of ERK and NF-κB during HARE-Mediated Heparin Uptake Require Only One of the Four Endocytic Motifs.Low-molecular-weight heparins and angiogenesis.Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivoCase series of cerebral infarction with Trousseau's syndrome associated with malignant gynecological tumorsThromboprophylaxis with low-molecular-weight heparin in medical patients with cancer.The effect of anticoagulant pharmacotherapy on fracture healing.Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.Cancer, clots and consensus: new understanding of an old problem.VEGF antagonist for the prevention of ovarian hyperstimulation syndrome: Current status.Low molecular weight heparins in the treatment of lung cancer.Microbial heparin/heparan sulphate lyases: potential and applications.Heparan sulfate-protein binding specificity.Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells.In vitro synthesis of heparosan using recombinant Pasteurella multocida heparosan synthase PmHS2.
P2860
Q28301882-2F279843-40EE-4AE3-BD5D-5329B34ED5F7Q33269554-630CD117-4975-467B-A88F-4AC43F70D6BCQ34721483-9A9DC0F2-B43A-4A05-AB9A-70943E5BAEC8Q34803861-9D410F6B-8540-435C-A245-6A66C41B0296Q35128227-011CDB5B-462A-4FD1-915C-CA7F76AC4DBDQ35174604-2532EA23-8940-4048-8B02-AE9C735F250DQ35324915-622D043F-5E22-4E9D-B52B-48FEA8AC022AQ35914011-AA47BE93-D4A4-4A8A-9272-749F0FB24B28Q35987516-43BBFBFC-60DA-477A-8156-0CF118A5F42DQ35995906-0CFA5BC3-D02D-4127-BDE2-B990689C8CF2Q36414904-8A3096EE-989B-40FB-BE09-052A9CE257BCQ36611135-E578E632-47F8-4B51-ABF4-B703E8145BD2Q37001486-727E4F7E-1259-4DA1-98D3-577A8599BCF8Q37023306-8DE0CBDB-97E4-40DE-99A7-835BDB567E51Q37142069-8398E5A5-9E11-4552-BC14-6D154A54F088Q37323266-D783AA1C-928D-4303-B38B-8AA808894C15Q37393386-DC428E41-3ADC-4C78-AF1E-A440D0714E5DQ37624402-666E6D1C-CCF0-4D4E-B487-699F333C5445Q37943009-4E1E5749-5063-40D2-B23D-85865DB48E26Q37990767-F02F7AF4-DDA6-4CA4-9532-C91450BACF07Q38134808-E359B0F9-A7CA-4354-A0AE-BB0C96E38F63Q38294916-2D01E04B-6762-4756-B465-42B2EE4B7AB5Q38974266-AE74E8B4-6CA4-48B5-9CD2-8ED13EB47395Q39243093-E7DC3BF9-C589-4453-9223-D5A2A4168D1EQ42127638-776DC22C-78B9-424A-965C-A29E5F16217B
P2860
The heparins and cancer: review of clinical trials and biological properties.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The heparins and cancer: review of clinical trials and biological properties.
@ast
The heparins and cancer: review of clinical trials and biological properties.
@en
type
label
The heparins and cancer: review of clinical trials and biological properties.
@ast
The heparins and cancer: review of clinical trials and biological properties.
@en
prefLabel
The heparins and cancer: review of clinical trials and biological properties.
@ast
The heparins and cancer: review of clinical trials and biological properties.
@en
P2093
P2860
P1433
P1476
The heparins and cancer: review of clinical trials and biological properties.
@en
P2093
Fernando Porro
Paolo Tarsia
Roberto Castelli
P2860
P304
P356
10.1191/1358863X04VM566RA
P577
2004-05-01T00:00:00Z